These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24151767)

  • 1. Circulating plasma and platelet 5-hydroxytryptamine in carcinoid heart disease: a pilot study.
    Bhattacharyya S; Jagroop A; Gujral DM; Hayward C; Toumpanakis C; Caplin M; Mikhailidis DP; Davar J
    J Heart Valve Dis; 2013 May; 22(3):400-7. PubMed ID: 24151767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
    Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoid Heart Disease in Patients With Bronchopulmonary Carcinoid.
    De Jesus T; Luis SA; Ryu JH; Molina JR; Connolly HM; Maleszewski JJ; Pellikka PA
    J Thorac Oncol; 2018 Oct; 13(10):1602-1605. PubMed ID: 30251640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.
    Robiolio PA; Rigolin VH; Wilson JS; Harrison JK; Sanders LL; Bashore TM; Feldman JM
    Circulation; 1995 Aug; 92(4):790-5. PubMed ID: 7641358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of left-sided carcinoid heart disease.
    Connolly HM; Schaff HV; Mullany CJ; Rubin J; Abel MD; Pellikka PA
    Circulation; 2001 Sep; 104(12 Suppl 1):I36-40. PubMed ID: 11568027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of carcinoid heart disease identified by cardiac computed tomography.
    Davar J; Lazoura O; Caplin ME; Toumpanakis C
    J Cardiovasc Comput Tomogr; 2021; 15(2):167-174. PubMed ID: 33004299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart involvement in metastatic carcinoid disease.
    Törnebrandt K; Eskilsson J; Nobin A
    Clin Cardiol; 1986 Jan; 9(1):13-9. PubMed ID: 3943230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Outcomes of Surgery for Carcinoid Heart Disease.
    Yong MS; Kong G; Ludhani P; Michael M; Morgan J; Hofman MS; Hicks RJ; Larobina M
    Heart Lung Circ; 2020 May; 29(5):742-747. PubMed ID: 31383543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoid Heart Valve Disease: Transcatheter Pulmonary Valve-In-Valve Implantation in Failing Biological Xenografts.
    Conradi L; Schaefer A; Mueller GC; Seiffert M; Gulbins H; Blankenberg S; Reichenspurner H; Treede H; Diemert P
    J Heart Valve Dis; 2015 Jan; 24(1):110-4. PubMed ID: 26182628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Carcinoid Heart Disease in the Modern Management Era.
    Baron E; Szymanski C; Hergault H; Lepère C; Dubourg O; Hauguel-Moreau M; Mansencal N
    J Am Heart Assoc; 2021 Dec; 10(23):e020475. PubMed ID: 34816734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treatment with bosentan in patients with carcinoid heart disease: single center study.
    Lafaras CT; Mandala EM; Platogiannis DN; Saratzis AN; Barbetakis NG; Paraskevopoulos PP; Ilonidis GC; Bischiniotis TS
    Onkologie; 2010; 33(6):300-4. PubMed ID: 20523093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues.
    Joish VN; Perez-Olle R; Lapuerta P; Dharba S; Zacks J
    Clin Ther; 2019 Sep; 41(9):1716-1723.e2. PubMed ID: 31326125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
    Rajamannan NM; Caplice N; Anthikad F; Sebo TJ; Orszulak TA; Edwards WD; Tajik J; Schwartz RS
    J Heart Valve Dis; 2001 Nov; 10(6):827-31. PubMed ID: 11767194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with carcinoid heart disease after valvular surgery.
    Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular abnormalities in patients with a carcinoid syndrome.
    Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
    Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and heart rate in hypertensive and normotensive subjects.
    Missouris CG; Cappuccio FP; Varsamis E; Barron JL; Carr E; Markandu ND; MacGregor GA
    Am Heart J; 1998 May; 135(5 Pt 1):838-43. PubMed ID: 9588414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.
    Khay K; Arous S; Bentaoune T; Drighil A; Habbal R
    J Med Case Rep; 2018 Jan; 12(1):23. PubMed ID: 29386066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular Disorders in Carcinoid Heart Disease.
    Yuan SM
    Braz J Cardiovasc Surg; 2016; 31(5):400-405. PubMed ID: 27982350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.
    Smith SA; Waggoner AD; de las Fuentes L; Davila-Roman VG
    J Am Soc Echocardiogr; 2009 Aug; 22(8):883-9. PubMed ID: 19553085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of left-sided heart valve involvement before right-sided heart valve involvement in carcinoid heart disease.
    Marupakula V; Vinales KL; Najib MQ; Lanza LA; Lee HR; Chaliki HP
    Eur J Echocardiogr; 2011 Mar; 12(3):E18. PubMed ID: 21169284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.